Search research articles
Contact Us
Filters
Showing results (151-160 of 181) with videos related to
Page
of 19
Sort By:
Scientific Reports
|
March 12, 2013
Detection and quantification of methylation in DNA using solid-state nanopores
Jiwook Shim, Gwendolyn I Humphreys, Bala Murali Venkatesan, et al.
Frontiers in Oncology
|
August 4, 2025
Case Report: A successful multidisciplinary approach to doxorubicin extravasation from a PICC-port in a patient with breast cancer
Concetta Calabrò, Serena Iacovelli, Giuseppe De Palma, et al.
Oncotarget
|
April 20, 2017
Immunotherapeutic approaches for hepatocellular carcinoma
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, et al.
The Journal of Cell Biology
|
May 5, 2010
Histone H1 phosphorylation is associated with transcription by RNA polymerases I and II
Yupeng Zheng, Sam John, James J Pesavento, et al.
World Journal of Gastroenterology
|
July 29, 2016
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
Amalia Azzariti, Letizia Porcelli, Oronzo Brunetti, et al.
Mbio
|
March 5, 2025
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, et al.
Mbio
|
April 13, 2026
Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies
Gagandeep Singh, Disha Bhavsar, Enikö Hermann, et al.
The Journal of Biological Chemistry
|
March 14, 2008
A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells
Chengjian Mao, Nicole M Patterson, Milu T Cherian, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination
Anass Abbad, Brian Lerman, Jordan Ehrenhaus, et al.
Mbio
|
November 25, 2025
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination
Anass Abbad, Brian Lerman, Jordan Ehrenhaus, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 181) with videos related to
Sort By:
Page
of 19
Scientific Reports
|
March 12, 2013
Detection and quantification of methylation in DNA using solid-state nanopores
Jiwook Shim, Gwendolyn I Humphreys, Bala Murali Venkatesan, et al.
Frontiers in Oncology
|
August 4, 2025
Case Report: A successful multidisciplinary approach to doxorubicin extravasation from a PICC-port in a patient with breast cancer
Concetta Calabrò, Serena Iacovelli, Giuseppe De Palma, et al.
Oncotarget
|
April 20, 2017
Immunotherapeutic approaches for hepatocellular carcinoma
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, et al.
The Journal of Cell Biology
|
May 5, 2010
Histone H1 phosphorylation is associated with transcription by RNA polymerases I and II
Yupeng Zheng, Sam John, James J Pesavento, et al.
World Journal of Gastroenterology
|
July 29, 2016
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
Amalia Azzariti, Letizia Porcelli, Oronzo Brunetti, et al.
Mbio
|
March 5, 2025
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, et al.
Mbio
|
April 13, 2026
Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies
Gagandeep Singh, Disha Bhavsar, Enikö Hermann, et al.
The Journal of Biological Chemistry
|
March 14, 2008
A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells
Chengjian Mao, Nicole M Patterson, Milu T Cherian, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination
Anass Abbad, Brian Lerman, Jordan Ehrenhaus, et al.
Mbio
|
November 25, 2025
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination
Anass Abbad, Brian Lerman, Jordan Ehrenhaus, et al.
Page
of 19